Journal
MEDICAL HYPOTHESES
Volume 149, Issue -, Pages -Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.mehy.2021.110534
Keywords
COVID-19; Bilirubin; Biliverdin; Nanomedicine; Anti-inflammatory; Antioxidant
Categories
Ask authors/readers for more resources
Bilirubin has various beneficial properties, including anti-inflammatory, antioxidant, and antiviral activities, and may act as a metabolic hormone with positive associations to several diseases. However, challenges in therapeutic delivery exist due to solubility issues. Nanotechnology offers unique advantages for improved delivery and potential use in combating COVID-19.
Bilirubin has been proven to possess significant anti-inflammatory, antioxidant and antiviral activities. Recently, it has been postulated as a metabolic hormone. Further, moderately higher levels of bilirubin are positively associated with reduced risk of cardiovascular diseases, diabetes, metabolic syndrome and obesity. However, due to poor solubility the therapeutic delivery of bilirubin remains a challenge. Nanotechnology offers unique advantages which may be exploited for improved delivery of bilirubin to the target organ with reduced risk of systemic toxicity. Herein, we postulate the use of intravenous administration or inhalational delivery of bilirubin nanomedicine (BNM) to combat systemic dysfunctions associated with COVID-19, owing to the remarkable preclinical efficacy and optimistic results of various clinical studies of bilirubin in non-communicable disorders. BNM may be used to harness the proven preclinical pharmacological efficacy of bilirubin against COVID-19 related systemic complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available